Disseminated sporotrichosis following iatrogenic immunosuppression for suspected pyoderma gangrenosum

Lancet Infect Dis. 2019 Nov;19(11):e385-e391. doi: 10.1016/S1473-3099(19)30421-9. Epub 2019 Aug 28.

Abstract

Sporotrichosis is an infection caused by the dimorphic fungus Sporothrix schenckii and related species that often arises from traumatic inoculation of inhabited soil and organic debris into skin. The infection is usually limited to the skin in immunocompetent patients, usually as lymphocutaneous sporotrichosis. Accurate diagnosis rests on clinical data and culture, and might be facilitated by biopsy identification of suppurative and granulomatous inflammation with fungal elements. In this Grand Round, we present a dramatic case of cutaneous sporotrichosis initially presented with an atypical large ulcer without associated lymphocutaneous spread, clinically mimicking pyoderma gangrenosum, and subsequently progressed to disseminated sporotrichosis in the setting of iatrogenic immunosuppression. We further review the clinical features, risk factors, and treatment of these disseminated sporotrichosis cases, and discuss the need for improved awareness of this fungus' potential link to cause disseminated and invasive fungal infections.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Biopsy
  • Histocytochemistry
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Immunosuppression Therapy / methods*
  • Male
  • Middle Aged
  • Pyoderma Gangrenosum / pathology*
  • Risk Factors
  • Sporothrix / isolation & purification*
  • Sporotrichosis / diagnosis*
  • Sporotrichosis / drug therapy
  • Sporotrichosis / pathology*

Substances

  • Antifungal Agents